KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Texas Instruments (TXN) Research & Development (2016 - 2025)

Historic Research & Development for Texas Instruments (TXN) over the last 17 years, with Q4 2025 value amounting to $521.0 million.

  • Texas Instruments' Research & Development rose 611.0% to $521.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 632.98%. This contributed to the annual value of $2.1 billion for FY2025, which is 632.98% up from last year.
  • According to the latest figures from Q4 2025, Texas Instruments' Research & Development is $521.0 million, which was up 611.0% from $518.0 million recorded in Q3 2025.
  • Texas Instruments' 5-year Research & Development high stood at $527.0 million for Q2 2025, and its period low was $386.0 million during Q1 2021.
  • For the 5-year period, Texas Instruments' Research & Development averaged around $456.4 million, with its median value being $465.5 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first increased by 25.77% in 2021, then skyrocketed by 1636.83% in 2023.
  • Quarter analysis of 5 years shows Texas Instruments' Research & Development stood at $389.0 million in 2021, then grew by 11.57% to $434.0 million in 2022, then increased by 5.99% to $460.0 million in 2023, then rose by 6.74% to $491.0 million in 2024, then increased by 6.11% to $521.0 million in 2025.
  • Its Research & Development stands at $521.0 million for Q4 2025, versus $518.0 million for Q3 2025 and $527.0 million for Q2 2025.